Pascal Edrich

550 total citations
13 papers, 449 citations indexed

About

Pascal Edrich is a scholar working on Psychiatry and Mental health, Pediatrics, Perinatology and Child Health and Cellular and Molecular Neuroscience. According to data from OpenAlex, Pascal Edrich has authored 13 papers receiving a total of 449 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Psychiatry and Mental health, 8 papers in Pediatrics, Perinatology and Child Health and 3 papers in Cellular and Molecular Neuroscience. Recurrent topics in Pascal Edrich's work include Epilepsy research and treatment (10 papers), Pharmacological Effects and Toxicity Studies (8 papers) and Neuroscience and Neuropharmacology Research (3 papers). Pascal Edrich is often cited by papers focused on Epilepsy research and treatment (10 papers), Pharmacological Effects and Toxicity Studies (8 papers) and Neuroscience and Neuropharmacology Research (3 papers). Pascal Edrich collaborates with scholars based in United States, Belgium and Switzerland. Pascal Edrich's co-authors include Joyce A. Cramer, Jacqueline A. French, Betty Van Vleymen, Josemir W. Sander, Elinor Ben‐Menachem, Bernd Schmidt, Chi‐Wan Lai, Jing‐Jane Tsai, Der‐Jen Yen and William E. Rosenfeld and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Epilepsia.

In The Last Decade

Pascal Edrich

13 papers receiving 432 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Pascal Edrich United States 9 377 343 160 65 38 13 449
Kıvılcım Gücüyener Türkiye 12 114 0.3× 145 0.4× 71 0.4× 16 0.2× 16 0.4× 33 357
J.A. Mauri Spain 13 329 0.9× 276 0.8× 173 1.1× 39 0.6× 15 0.4× 21 451
T. Goggin Ireland 8 355 0.9× 386 1.1× 82 0.5× 43 0.7× 21 0.6× 10 464
J. Porcel Spain 9 122 0.3× 79 0.2× 27 0.2× 98 1.5× 14 0.4× 12 458
Y. Sturm Switzerland 9 422 1.1× 418 1.2× 114 0.7× 66 1.0× 26 0.7× 11 513
Simon Borghs United Kingdom 14 592 1.6× 529 1.5× 270 1.7× 56 0.9× 39 1.0× 39 660
C. Arrigo Belgium 9 348 0.9× 315 0.9× 133 0.8× 84 1.3× 24 0.6× 14 486
E.L. Mullens United Kingdom 4 450 1.2× 406 1.2× 131 0.8× 53 0.8× 10 0.3× 5 532
Daniela Mamoli Italy 12 274 0.7× 324 0.9× 57 0.4× 53 0.8× 2 0.1× 16 467
Evren Burakgazi-Dalkilic United States 7 271 0.7× 231 0.7× 115 0.7× 50 0.8× 36 0.9× 10 351

Countries citing papers authored by Pascal Edrich

Since Specialization
Citations

This map shows the geographic impact of Pascal Edrich's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pascal Edrich with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pascal Edrich more than expected).

Fields of papers citing papers by Pascal Edrich

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pascal Edrich. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pascal Edrich. The network helps show where Pascal Edrich may publish in the future.

Co-authorship network of co-authors of Pascal Edrich

This figure shows the co-authorship network connecting the top 25 collaborators of Pascal Edrich. A scholar is included among the top collaborators of Pascal Edrich based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pascal Edrich. Pascal Edrich is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Izem, Rima, Emmanuel Zuber, Nadia Daizadeh, et al.. (2024). Decentralized Clinical Trials: Scientific Considerations Through the Lens of the Estimand Framework. Therapeutic Innovation & Regulatory Science. 58(3). 495–504. 7 indexed citations
2.
3.
Kwan, Patrick, Shih Hui Lim, Yotin Chinvarun, et al.. (2010). Efficacy and safety of levetiracetam as adjunctive therapy in adult patients with uncontrolled partial epilepsy: The Asia SKATE II Study. Epilepsy & Behavior. 18(1-2). 100–105. 18 indexed citations
4.
Larson, Richard A., Phillipp D. Le Coutre, Josy Reiffers, et al.. (2010). Comparison of nilotinib and imatinib in patients (pts) with newly diagnosed chronic myeloid leukemia in chronic phase (CML-CP): ENESTnd beyond one year.. Journal of Clinical Oncology. 28(15_suppl). 6501–6501. 31 indexed citations
5.
Rosenfeld, William E., Selim R. Benbadis, Pascal Edrich, C. A. Tassinari, & Édouard Hirsch. (2009). Levetiracetam as add-on therapy for idiopathic generalized epilepsy syndromes with onset during adolescence: Analysis of two randomized, double-blind, placebo-controlled studies. Epilepsy Research. 85(1). 72–80. 39 indexed citations
6.
Trinka, Eugen, Wim Van Paesschen, Yngve Hallström, et al.. (2008). The komet study: an open-label, randomized, parallel-group trial comparing the efficacy and safety of levetiracetam with sodium valproate and carbamazepine as monotherapy in subjects with newly diagnosed epilepsy. Epilepsia. 49. 448–449. 5 indexed citations
7.
8.
9.
10.
Edrich, Pascal, et al.. (2006). Identifying baseline characteristics of placebo responders versus nonresponders in randomized double-blind trials of refractory partial-onset seizures.. PubMed. 8(1). 37–44. 19 indexed citations
11.
Leppik, Ilo E., et al.. (2006). Measurement of seizure freedom in adjunctive therapy studies in refractory partial epilepsy: the levetiracetam experience. Epileptic Disorders. 8(2). 118–130. 19 indexed citations
12.
Ben‐Menachem, Elinor, Pascal Edrich, Betty Van Vleymen, Josemir W. Sander, & Bernd Schmidt. (2003). Evidence for sustained efficacy of levetiracetam as add-on epilepsy therapy. Epilepsy Research. 53(1-2). 57–64. 66 indexed citations
13.
French, Jacqueline A., Pascal Edrich, & Joyce A. Cramer. (2001). A systematic review of the safety profile of levetiracetam: a new antiepileptic drug. Epilepsy Research. 47(1-2). 77–90. 162 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kıvılcım Gücüyener Breakdown of academic impact, for papers by J.A. Mauri Breakdown of academic impact, for papers by T. Goggin Breakdown of academic impact, for papers by J. Porcel Breakdown of academic impact, for papers by Y. Sturm Breakdown of academic impact, for papers by Simon Borghs Breakdown of academic impact, for papers by C. Arrigo Breakdown of academic impact, for papers by E.L. Mullens Breakdown of academic impact, for papers by Daniela Mamoli Breakdown of academic impact, for papers by Evren Burakgazi-Dalkilic
Rankless by CCL
2026